Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 866 entries
View as:

A Study to Evaluate Satisfaction in Adult Participants With the Aesthetics of the Periorbital Area After JUVÉDERM® Fillers and BOTOX®/VISTABEL® Injections

Phase: N/A Priority: Normal
NCT ID: NCT05647551 Org: User:
Start: 01/05/23 End: 10/05/23 Due: 10/05/24

A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04837482 Org: User:
Start: 05/14/21 End: 12/07/21 Due: 12/07/22

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03982394 Org: User:
Start: 07/01/19 End: 07/30/25 Due: 07/30/26

Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02052349 Org: User:
Start: 11/30/13 End: 12/31/13 Due: 12/31/14

Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT02031276 Org: User:
Start: 02/28/14 End: 11/30/16 Due: 11/30/17

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets

Phase: N/A Priority: Normal
NCT ID: NCT05215639 Org: User:
Start: 12/27/21 End: 11/14/25 Due: 11/14/26

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT03178487 Org: User:
Start: 10/24/17 End: 02/17/22 Due: 02/17/23

Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT01800695 Org: User:
Start: 04/02/13 End: 06/19/17 Due: 06/19/18

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT03271489 Org: User:
Start: 01/04/17 End: 06/28/24 Due: 06/28/25

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02442284 Org: User:
Start: 05/13/15 End: 10/31/16 Due: 10/31/17

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02399345 Org: User:
Start: 03/31/15 End: 11/30/15 Due: 11/30/16

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

Phase: N/A Priority: Normal
NCT ID: NCT03781167 Org: User:
Start: 04/29/19 End: 08/17/22 Due: 08/17/23

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03737812 Org: User:
Start: 02/27/19 End: 08/30/21 Due: 08/30/22

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT03342144 Org: User:
Start: 12/04/17 End: 12/31/25 Due: 12/31/26

A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04497597 Org: User:
Start: 10/16/20 End: 05/15/24 Due: 05/15/25

ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT02517515 Org: User:
Start: 07/31/15 End: 06/30/17 Due: 06/30/18

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02219477 Org: User:
Start: 11/24/14 End: 03/03/17 Due: 03/03/18

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT05028569 Org: User:
Start: 11/05/21 End: 11/06/24 Due: 11/06/25

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07005102 Org: User:
Start: 09/08/25 End: 12/31/31 Due: 12/31/32

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Phase: N/A Priority: Normal
NCT ID: NCT07007065 Org: User:
Start: 09/17/25 End: 03/31/33 Due: 03/31/34

Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06300580 Org: User:
Start: 08/21/24 End: 05/26/25 Due: 05/26/26

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

Phase: N/A Priority: Normal
NCT ID: NCT03339128 Org: User:
Start: 11/15/17 End: 12/31/26 Due: 12/31/27

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06764706 Org: User:
Start: 02/27/25 End: 07/31/28 Due: 07/31/29

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Phase: N/A Priority: Normal
NCT ID: NCT03341871 Org: User:
Start: 12/27/17 End: 09/15/20 Due: 09/15/21

A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03625505 Org: User:
Start: 10/18/18 End: 08/31/21 Due: 08/31/22